Vivos Inc. (OTCQB: RDGL) is pleased to announce the significant achievements of its IsoPet® Animal Cancer Division, setting new milestones in veterinary cancer care, and expanding its network of certified clinics across the U.S.
A Message from Vivos Inc. CEO, Dr. Michael Korenko
“Over the last two years, we focused on identifying the most effective marketing approaches, and those efforts are now paying off. Our priority for 2025 and 2026 is to expand our network of small animal, equine, and exotic clinics while increasing the number of patients benefiting from IsoPet®’s innovative treatments. Clinics appreciate the low-cost certification process, and pet owners value IsoPet®’s one-time effective therapies.”
Read the full press release here.

